Vanguard (NYSE: CME) reports 36.25M shares, cites 01/12/2026 realignment
Rhea-AI Filing Summary
CME Group Inc: The Vanguard Group filed Amendment No. 9 to a Schedule 13G/A reporting 36,248,559 shares beneficially owned, representing 10.10% of common stock. The filing states shared voting power 3,697,661 and shared dispositive power 36,248,559. It notes an internal realignment effective 01/12/2026 that changed portfolio management and proxy voting roles within The Vanguard Group, Inc.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a 10.10% stake with shared control; holdings remain substantial.
The filing lists 36,248,559 shares beneficially owned and 10.10% of the class, with shared voting power 3,697,661. This indicates significant economic exposure while voting influence is distributed among Vanguard entities.
Investor attention should focus on future amendments from Vanguard subsidiaries after the 01/12/2026 realignment; subsequent filings may disclose narrower, disaggregated ownership by those subsidiaries.
Amendment cites internal reorganization and reliance on SEC release for disaggregation.
The statement references SEC Release No. 34-39538 and says Vanguard anticipates reporting by subsidiaries on a disaggregated basis following the 01/12/2026 realignment. The filing is signed by the Head of Global Fund Administration on 03/05/2026.
Compliance observers should watch for further Schedule 13G/A or 13D filings from Vanguard affiliates that reflect redistributed voting or dispositive powers.